Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13 - what is the next step for this reasearch - Siqing Fu M.D. Ph.D. MD Anderson C...

Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13 - what is the next step for this reasearch - Siqing Fu M.D. Ph.D. MD Anderson C...

User Photo
Cancer-News

1 month
14 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center discusses Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13


https://www.firstwordpharma.com/node/1731315
Up Next Autoplay